A Transposon-Associated CRISPR/Cas9 System Specifically Eliminates both Chromosomal and Plasmid-Borne mcr-1 in

Yu-Zhang He1,2,3,4, Jin-Ru Yan1,2,3, Bing He1,2,3

  • 1National Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, College of Veterinary Medicine, South China Agricultural University, Guangzhou, China.

Insights

A novel CRISPR/Cas9 system effectively eliminates the mcr-1 gene, a colistin resistance factor, from bacteria. This approach restores colistin sensitivity and prevents further spread of antimicrobial resistance.

Area of Science:

  • Microbiology
  • Genetics
  • Molecular Biology

Background:

  • Antimicrobial resistance, particularly to last-resort antibiotics like colistin, is a major global public health threat.
  • The mcr-1 gene, conferring colistin resistance, is rapidly spreading among Enterobacteriaceae species, often facilitated by mobile genetic elements like transposons.
  • Existing treatments are becoming less effective against resistant bacterial strains.

Purpose of the Study:

  • To develop a targeted gene-editing strategy to eliminate the mcr-1 gene from bacteria.
  • To assess the efficacy of a CRISPR/Cas9 system in combating colistin resistance.
  • To investigate the potential of this system as a therapeutic approach against antimicrobial resistance.

Main Methods:

  • Development of a suicide plasmid carrying an ISApl1-flanked CRISPR/Cas9 system.
  • Application of the system to target and eliminate both plasmid-borne and chromosome-borne mcr-1 genes.
  • Evaluation of bacterial sensitivity to colistin post-treatment.
  • Assessment of immunity against exogenous mcr-1 acquisition.

Main Results:

  • The CRISPR/Cas9 system successfully removed the mcr-1 gene from Escherichia coli, restoring colistin sensitivity.
  • The system demonstrated efficacy against both plasmid-mediated and chromosomally-located mcr-1.
  • Treated bacteria exhibited resistance to acquiring new mcr-1 genes via plasmids.
  • High efficiency in gene curing and bacterial eradication was observed.

Conclusions:

  • The transposon-associated CRISPR/Cas9 system is a potent tool for eradicating the mcr-1 gene.
  • This technology offers a promising therapeutic strategy to combat colistin resistance and control the spread of antimicrobial resistance in clinical settings.

Related Concept Videos

CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
716
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
53.6K
CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.9K
The Antiviral System of Bacteria and Archaea: CRISPR01:23

The Antiviral System of Bacteria and Archaea: CRISPR

CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
304